Franklin Covey Co: Form 10-Q for the period ended Nov 30, 2021
Filed with the SEC on Jan 7, 2022 and accepted by EDGAR at Jan 7, 2022, 13:45 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-11-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-09-01 to 2021-11-30 | $61.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2021-09-01 to 2021-11-30 | $13.7m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2021-09-01 to 2021-11-30 | $47.6m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2021-09-01 to 2021-11-30 | $39.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2021-09-01 to 2021-11-30 | $5.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2021-09-01 to 2021-11-30 | $446.0k | us-gaap:InterestExpense |
| Income tax | 3 months2021-09-01 to 2021-11-30 | $1.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-09-01 to 2021-11-30 | $3.8m | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months2021-09-01 to 2021-11-30 | 14,312,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2021-09-01 to 2021-11-30 | $10.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2021-09-01 to 2021-11-30 | $520.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months2021-09-01 to 2021-11-30 | $3.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2021-11-30 | $51.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-11-30 | $121.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-11-30 | $230.7m | us-gaap:Assets |
| Current liabilities | At period end2021-11-30 | $118.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-11-30 | $148.6m | us-gaap:Liabilities |
| Shareholders' equity | At period end2021-11-30 | $82.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000886206-22-000005. Last ingested by Listed: Nov 4, 2026, 17:30 ET. Listed shows no prices and gives no investment advice.